APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human BMP-2

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Recombinant Human BMP-2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025195 pages

Choose your research edition.

Industry ResearchRecombinant Human BMP-2 Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human BMP-2 Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Recombinant Human BMP-2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human BMP-2 Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human BMP-2 Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Recombinant Human BMP-2 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Recombinant Human BMP-2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Recombinant Human BMP-2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Human BMP-2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Recombinant Human BMP-2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Human BMP-2 include 赛默飞世尔, Yeasen Biotechnology (Shanghai), Yantai Zhenghai Bio-Tech, Abbkine Scientific, WEIGAO, Shanghai Zhong Qiao Xin Zhou Biotechnology, Shanghai NovoPro, HANGZHOU JIUYUAN GENE ENGINEERIN and Beijing Baiaolaibo Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Recombinant Human BMP-2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Recombinant Human BMP-2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Recombinant Human BMP-2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Recombinant Human BMP-2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Recombinant Human BMP-2 Segment by Company

赛默飞世尔

Yeasen Biotechnology (Shanghai)

Yantai Zhenghai Bio-Tech

Abbkine Scientific

WEIGAO

Shanghai Zhong Qiao Xin Zhou Biotechnology

Shanghai NovoPro

HANGZHOU JIUYUAN GENE ENGINEERIN

Beijing Baiaolaibo Technology

STEMCELL Technologies

Sigma Aldrich

Proteintech

CUSABIO TECHNOLOGY

Cgbio

Cell Guidance Systems

Biomol GmbH

Recombinant Human BMP-2 Segment by Type

Powder

Sponge

Others

Recombinant Human BMP-2 Segment by Application

Hospital

Research Institute

Others

Recombinant Human BMP-2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human BMP-2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human BMP-2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human BMP-2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Recombinant Human BMP-2 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Human BMP-2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Recombinant Human BMP-2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Recombinant Human BMP-2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Recombinant Human BMP-2 Industry Trends Table 2. Recombinant Human BMP-2 Industry Drivers Table 3. Recombinant Human BMP-2 Industry Opportunities and Challenges Table 4. Recombinant Human BMP-2 Industry Restraints Table 5. Global Recombinant Human BMP-2 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Recombinant Human BMP-2 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Recombinant Human BMP-2 Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Recombinant Human BMP-2 Sales Market Share by Manufacturers Table 9. Global Recombinant Human BMP-2 Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global Recombinant Human BMP-2 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Recombinant Human BMP-2 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Recombinant Human BMP-2 Manufacturers, Product Type & Application Table 13. Global Recombinant Human BMP-2 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Recombinant Human BMP-2 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Powder Table 17. Major Manufacturers of Sponge Table 18. Major Manufacturers of Others Table 19. Global Recombinant Human BMP-2 Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Recombinant Human BMP-2 Sales by Type (2021-2026) & (Kg) Table 21. Global Recombinant Human BMP-2 Sales by Type (2027-2032) & (Kg) Table 22. Global Recombinant Human BMP-2 Sales Market Share by Type (2021-2026) Table 23. Global Recombinant Human BMP-2 Sales Market Share by Type (2027-2032) Table 24. Global Recombinant Human BMP-2 Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 25. Global Recombinant Human BMP-2 Revenue by Type (2021-2026) & (Kg) Table 26. Global Recombinant Human BMP-2 Revenue by Type (2027-2032) & (Kg) Table 27. Global Recombinant Human BMP-2 Revenue Market Share by Type (2021-2026) Table 28. Global Recombinant Human BMP-2 Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Research Institute Table 31. Major Manufacturers of Others Table 32. Global Recombinant Human BMP-2 Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global Recombinant Human BMP-2 Sales by Application (2021-2026) & (Kg) Table 34. Global Recombinant Human BMP-2 Sales by Application (2027-2032) & (Kg) Table 35. Global Recombinant Human BMP-2 Sales Market Share by Application (2021-2026) Table 36. Global Recombinant Human BMP-2 Sales Market Share by Application (2027-2032) Table 37. Global Recombinant Human BMP-2 Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 38. Global Recombinant Human BMP-2 Revenue by Application (2021-2026) & (Kg) Table 39. Global Recombinant Human BMP-2 Revenue by Application (2027-2032) & (Kg) Table 40. Global Recombinant Human BMP-2 Revenue Market Share by Application (2021-2026) Table 41. Global Recombinant Human BMP-2 Revenue Market Share by Application (2027-2032) Table 42. Global Recombinant Human BMP-2 Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global Recombinant Human BMP-2 Sales by Region (2021-2026) & (Kg) Table 44. Global Recombinant Human BMP-2 Sales Market Share by Region (2021-2026) Table 45. Global Recombinant Human BMP-2 Sales Forecasted by Region (2027-2032) & (Kg) Table 46. Global Recombinant Human BMP-2 Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Recombinant Human BMP-2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 48. North America Recombinant Human BMP-2 Sales by Country (2021-2026) & (Kg) Table 49. North America Recombinant Human BMP-2 Sales by Country (2027-2032) & (Kg) Table 50. Europe Recombinant Human BMP-2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 51. Europe Recombinant Human BMP-2 Sales by Country (2021-2026) & (Kg) Table 52. Europe Recombinant Human BMP-2 Sales by Country (2027-2032) & (Kg) Table 53. Asia Pacific Recombinant Human BMP-2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 54. Asia Pacific Recombinant Human BMP-2 Sales by Country (2021-2026) & (Kg) Table 55. Asia Pacific Recombinant Human BMP-2 Sales by Country (2027-2032) & (Kg) Table 56. South America, Middle East and Africa Recombinant Human BMP-2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 57. South America, Middle East and Africa Recombinant Human BMP-2 Sales by Country (2021-2026) & (Kg) Table 58. South America, Middle East and Africa Recombinant Human BMP-2 Sales by Country (2027-2032) & (Kg) Table 59. Global Recombinant Human BMP-2 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Recombinant Human BMP-2 Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Recombinant Human BMP-2 Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Recombinant Human BMP-2 Revenue Market Share by Region (2021-2026) Table 63. Global Recombinant Human BMP-2 Revenue Market Share by Region (2027-2032) Table 64. 赛默飞世尔 Company Information Table 65. 赛默飞世尔 Business Overview Table 66. 赛默飞世尔 Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. 赛默飞世尔 Recombinant Human BMP-2 Product Portfolio Table 68. 赛默飞世尔 Recent Development Table 69. Yeasen Biotechnology (Shanghai) Company Information Table 70. Yeasen Biotechnology (Shanghai) Business Overview Table 71. Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Product Portfolio Table 73. Yeasen Biotechnology (Shanghai) Recent Development Table 74. Yantai Zhenghai Bio-Tech Company Information Table 75. Yantai Zhenghai Bio-Tech Business Overview Table 76. Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Product Portfolio Table 78. Yantai Zhenghai Bio-Tech Recent Development Table 79. Abbkine Scientific Company Information Table 80. Abbkine Scientific Business Overview Table 81. Abbkine Scientific Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Abbkine Scientific Recombinant Human BMP-2 Product Portfolio Table 83. Abbkine Scientific Recent Development Table 84. WEIGAO Company Information Table 85. WEIGAO Business Overview Table 86. WEIGAO Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. WEIGAO Recombinant Human BMP-2 Product Portfolio Table 88. WEIGAO Recent Development Table 89. Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information Table 90. Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview Table 91. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Product Portfolio Table 93. Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Development Table 94. Shanghai NovoPro Company Information Table 95. Shanghai NovoPro Business Overview Table 96. Shanghai NovoPro Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Shanghai NovoPro Recombinant Human BMP-2 Product Portfolio Table 98. Shanghai NovoPro Recent Development Table 99. HANGZHOU JIUYUAN GENE ENGINEERIN Company Information Table 100. HANGZHOU JIUYUAN GENE ENGINEERIN Business Overview Table 101. HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Product Portfolio Table 103. HANGZHOU JIUYUAN GENE ENGINEERIN Recent Development Table 104. Beijing Baiaolaibo Technology Company Information Table 105. Beijing Baiaolaibo Technology Business Overview Table 106. Beijing Baiaolaibo Technology Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Beijing Baiaolaibo Technology Recombinant Human BMP-2 Product Portfolio Table 108. Beijing Baiaolaibo Technology Recent Development Table 109. STEMCELL Technologies Company Information Table 110. STEMCELL Technologies Business Overview Table 111. STEMCELL Technologies Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. STEMCELL Technologies Recombinant Human BMP-2 Product Portfolio Table 113. STEMCELL Technologies Recent Development Table 114. Sigma Aldrich Company Information Table 115. Sigma Aldrich Business Overview Table 116. Sigma Aldrich Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Sigma Aldrich Recombinant Human BMP-2 Product Portfolio Table 118. Sigma Aldrich Recent Development Table 119. Proteintech Company Information Table 120. Proteintech Business Overview Table 121. Proteintech Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Proteintech Recombinant Human BMP-2 Product Portfolio Table 123. Proteintech Recent Development Table 124. CUSABIO TECHNOLOGY Company Information Table 125. CUSABIO TECHNOLOGY Business Overview Table 126. CUSABIO TECHNOLOGY Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. CUSABIO TECHNOLOGY Recombinant Human BMP-2 Product Portfolio Table 128. CUSABIO TECHNOLOGY Recent Development Table 129. Cgbio Company Information Table 130. Cgbio Business Overview Table 131. Cgbio Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Cgbio Recombinant Human BMP-2 Product Portfolio Table 133. Cgbio Recent Development Table 134. Cell Guidance Systems Company Information Table 135. Cell Guidance Systems Business Overview Table 136. Cell Guidance Systems Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Cell Guidance Systems Recombinant Human BMP-2 Product Portfolio Table 138. Cell Guidance Systems Recent Development Table 139. Biomol GmbH Company Information Table 140. Biomol GmbH Business Overview Table 141. Biomol GmbH Recombinant Human BMP-2 Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Biomol GmbH Recombinant Human BMP-2 Product Portfolio Table 143. Biomol GmbH Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Recombinant Human BMP-2 Distributors List Table 147. Recombinant Human BMP-2 Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Recombinant Human BMP-2 Product Image Figure 2. Global Recombinant Human BMP-2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human BMP-2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Human BMP-2 Sales (2021-2032) & (Kg) Figure 5. Global Recombinant Human BMP-2 Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 Recombinant Human BMP-2 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Powder Image Figure 9. Sponge Image Figure 10. Others Image Figure 11. Global Recombinant Human BMP-2 Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Recombinant Human BMP-2 Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Recombinant Human BMP-2 Sales Market Share by Type (2021-2032) Figure 14. Global Recombinant Human BMP-2 Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 15. Global Recombinant Human BMP-2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Recombinant Human BMP-2 Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Research Institute Image Figure 19. Others Image Figure 20. Global Recombinant Human BMP-2 Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global Recombinant Human BMP-2 Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Recombinant Human BMP-2 Sales Market Share by Application (2021-2032) Figure 23. Global Recombinant Human BMP-2 Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global Recombinant Human BMP-2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Recombinant Human BMP-2 Revenue Market Share by Application (2021-2032) Figure 26. North America Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 27. North America Recombinant Human BMP-2 Sales Market Share by Country (2021-2032) Figure 28. U.S. Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Canada Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Mexico Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Europe Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 32. Europe Recombinant Human BMP-2 Sales Market Share by Country (2021-2032) Figure 33. Germany Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 34. France Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 35. U.K. Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Italy Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Netherlands Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Asia Pacific Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Asia Pacific Recombinant Human BMP-2 Sales Market Share by Country (2021-2032) Figure 40. China Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Japan Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 42. South Korea Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Southeast Asia Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 44. India Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 45. Australia Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 46. South America, Middle East and Africa Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 47. South America, Middle East and Africa Recombinant Human BMP-2 Sales Market Share by Country (2021-2032) Figure 48. Brazil Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 49. South Africa Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Saudi Arabia Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 51. Turkey Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Argentina Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 53. UAE Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Egypt Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Chile Recombinant Human BMP-2 Sales and Growth Rate (2021-2032) & (Kg) Figure 56. Global Recombinant Human BMP-2 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Recombinant Human BMP-2 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Figure 59. North America Recombinant Human BMP-2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Figure 61. Europe Recombinant Human BMP-2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Recombinant Human BMP-2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Recombinant Human BMP-2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Recombinant Human BMP-2 Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Recombinant Human BMP-2 Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Sponge
  • Others
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • 赛默飞世尔
  • Yeasen Biotechnology (Shanghai)
  • Yantai Zhenghai Bio-Tech
  • Abbkine Scientific
  • WEIGAO
  • Shanghai Zhong Qiao Xin Zhou Biotechnology
  • Shanghai NovoPro
  • HANGZHOU JIUYUAN GENE ENGINEERIN
  • Beijing Baiaolaibo Technology
  • STEMCELL Technologies
  • Sigma Aldrich
  • Proteintech
  • CUSABIO TECHNOLOGY
  • Cgbio
  • Cell Guidance Systems
  • Biomol GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Recombinant Human BMP-2 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Recombinant Human BMP-2 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Recombinant Human BMP-2 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Recombinant Human BMP-2 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Recombinant Human BMP-2 Market Dynamics
  1. 2.1 Recombinant Human BMP-2 Industry Trends
  2. 2.2 Recombinant Human BMP-2 Industry Drivers
  3. 2.3 Recombinant Human BMP-2 Industry Opportunities and Challenges
  4. 2.4 Recombinant Human BMP-2 Industry Restraints
3 Recombinant Human BMP-2 Market by Manufacturers
  1. 3.1 Global Recombinant Human BMP-2 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Recombinant Human BMP-2 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Recombinant Human BMP-2 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Recombinant Human BMP-2 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Human BMP-2 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Recombinant Human BMP-2 Manufacturers, Product Type & Application
  7. 3.7 Global Recombinant Human BMP-2 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Human BMP-2 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Human BMP-2 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Human BMP-2 Tier 1, Tier 2, and Tier 3
4 Recombinant Human BMP-2 Market by Type
  1. 4.1 Recombinant Human BMP-2 Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Sponge
  4. 4.1.3 Others
  5. 4.2 Global Recombinant Human BMP-2 Sales by Type
  6. 4.2.1 Global Recombinant Human BMP-2 Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Recombinant Human BMP-2 Sales by Type (2021-2032)
  8. 4.2.3 Global Recombinant Human BMP-2 Sales Market Share by Type (2021-2032)
  9. 4.3 Global Recombinant Human BMP-2 Revenue by Type
  10. 4.3.1 Global Recombinant Human BMP-2 Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Recombinant Human BMP-2 Revenue by Type (2021-2032)
  12. 4.3.3 Global Recombinant Human BMP-2 Revenue Market Share by Type (2021-2032)
5 Recombinant Human BMP-2 Market by Application
  1. 5.1 Recombinant Human BMP-2 Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Research Institute
  4. 5.1.3 Others
  5. 5.2 Global Recombinant Human BMP-2 Sales by Application
  6. 5.2.1 Global Recombinant Human BMP-2 Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant Human BMP-2 Sales by Application (2021-2032)
  8. 5.2.3 Global Recombinant Human BMP-2 Sales Market Share by Application (2021-2032)
  9. 5.3 Global Recombinant Human BMP-2 Revenue by Application
  10. 5.3.1 Global Recombinant Human BMP-2 Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Recombinant Human BMP-2 Revenue by Application (2021-2032)
  12. 5.3.3 Global Recombinant Human BMP-2 Revenue Market Share by Application (2021-2032)
6 Global Recombinant Human BMP-2 Sales by Region
  1. 6.1 Global Recombinant Human BMP-2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Recombinant Human BMP-2 Sales by Region (2021-2032)
  3. 6.2.1 Global Recombinant Human BMP-2 Sales by Region (2021-2026)
  4. 6.2.2 Global Recombinant Human BMP-2 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Recombinant Human BMP-2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Recombinant Human BMP-2 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Recombinant Human BMP-2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Recombinant Human BMP-2 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Recombinant Human BMP-2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Recombinant Human BMP-2 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Recombinant Human BMP-2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Recombinant Human BMP-2 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Recombinant Human BMP-2 Revenue by Region
  1. 7.1 Global Recombinant Human BMP-2 Revenue by Region
  2. 7.1.1 Global Recombinant Human BMP-2 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Recombinant Human BMP-2 Revenue by Region (2021-2026)
  4. 7.1.3 Global Recombinant Human BMP-2 Revenue by Region (2027-2032)
  5. 7.1.4 Global Recombinant Human BMP-2 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Recombinant Human BMP-2 Revenue (2021-2032)
  8. 7.2.2 North America Recombinant Human BMP-2 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Recombinant Human BMP-2 Revenue (2021-2032)
  11. 7.3.2 Europe Recombinant Human BMP-2 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Recombinant Human BMP-2 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Recombinant Human BMP-2 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Recombinant Human BMP-2 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Recombinant Human BMP-2 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 赛默飞世尔
  2. 8.1.1 赛默飞世尔 Company Information
  3. 8.1.2 赛默飞世尔 Business Overview
  4. 8.1.3 赛默飞世尔 Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 赛默飞世尔 Recombinant Human BMP-2 Product Portfolio
  6. 8.1.5 赛默飞世尔 Recent Developments
  7. 8.2 Yeasen Biotechnology (Shanghai)
  8. 8.2.1 Yeasen Biotechnology (Shanghai) Company Information
  9. 8.2.2 Yeasen Biotechnology (Shanghai) Business Overview
  10. 8.2.3 Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Product Portfolio
  12. 8.2.5 Yeasen Biotechnology (Shanghai) Recent Developments
  13. 8.3 Yantai Zhenghai Bio-Tech
  14. 8.3.1 Yantai Zhenghai Bio-Tech Company Information
  15. 8.3.2 Yantai Zhenghai Bio-Tech Business Overview
  16. 8.3.3 Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Product Portfolio
  18. 8.3.5 Yantai Zhenghai Bio-Tech Recent Developments
  19. 8.4 Abbkine Scientific
  20. 8.4.1 Abbkine Scientific Company Information
  21. 8.4.2 Abbkine Scientific Business Overview
  22. 8.4.3 Abbkine Scientific Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Abbkine Scientific Recombinant Human BMP-2 Product Portfolio
  24. 8.4.5 Abbkine Scientific Recent Developments
  25. 8.5 WEIGAO
  26. 8.5.1 WEIGAO Company Information
  27. 8.5.2 WEIGAO Business Overview
  28. 8.5.3 WEIGAO Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WEIGAO Recombinant Human BMP-2 Product Portfolio
  30. 8.5.5 WEIGAO Recent Developments
  31. 8.6 Shanghai Zhong Qiao Xin Zhou Biotechnology
  32. 8.6.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
  33. 8.6.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview
  34. 8.6.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Product Portfolio
  36. 8.6.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments
  37. 8.7 Shanghai NovoPro
  38. 8.7.1 Shanghai NovoPro Company Information
  39. 8.7.2 Shanghai NovoPro Business Overview
  40. 8.7.3 Shanghai NovoPro Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai NovoPro Recombinant Human BMP-2 Product Portfolio
  42. 8.7.5 Shanghai NovoPro Recent Developments
  43. 8.8 HANGZHOU JIUYUAN GENE ENGINEERIN
  44. 8.8.1 HANGZHOU JIUYUAN GENE ENGINEERIN Company Information
  45. 8.8.2 HANGZHOU JIUYUAN GENE ENGINEERIN Business Overview
  46. 8.8.3 HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Product Portfolio
  48. 8.8.5 HANGZHOU JIUYUAN GENE ENGINEERIN Recent Developments
  49. 8.9 Beijing Baiaolaibo Technology
  50. 8.9.1 Beijing Baiaolaibo Technology Company Information
  51. 8.9.2 Beijing Baiaolaibo Technology Business Overview
  52. 8.9.3 Beijing Baiaolaibo Technology Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Beijing Baiaolaibo Technology Recombinant Human BMP-2 Product Portfolio
  54. 8.9.5 Beijing Baiaolaibo Technology Recent Developments
  55. 8.10 STEMCELL Technologies
  56. 8.10.1 STEMCELL Technologies Company Information
  57. 8.10.2 STEMCELL Technologies Business Overview
  58. 8.10.3 STEMCELL Technologies Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 STEMCELL Technologies Recombinant Human BMP-2 Product Portfolio
  60. 8.10.5 STEMCELL Technologies Recent Developments
  61. 8.11 Sigma Aldrich
  62. 8.11.1 Sigma Aldrich Company Information
  63. 8.11.2 Sigma Aldrich Business Overview
  64. 8.11.3 Sigma Aldrich Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sigma Aldrich Recombinant Human BMP-2 Product Portfolio
  66. 8.11.5 Sigma Aldrich Recent Developments
  67. 8.12 Proteintech
  68. 8.12.1 Proteintech Company Information
  69. 8.12.2 Proteintech Business Overview
  70. 8.12.3 Proteintech Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Proteintech Recombinant Human BMP-2 Product Portfolio
  72. 8.12.5 Proteintech Recent Developments
  73. 8.13 CUSABIO TECHNOLOGY
  74. 8.13.1 CUSABIO TECHNOLOGY Company Information
  75. 8.13.2 CUSABIO TECHNOLOGY Business Overview
  76. 8.13.3 CUSABIO TECHNOLOGY Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CUSABIO TECHNOLOGY Recombinant Human BMP-2 Product Portfolio
  78. 8.13.5 CUSABIO TECHNOLOGY Recent Developments
  79. 8.14 Cgbio
  80. 8.14.1 Cgbio Company Information
  81. 8.14.2 Cgbio Business Overview
  82. 8.14.3 Cgbio Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cgbio Recombinant Human BMP-2 Product Portfolio
  84. 8.14.5 Cgbio Recent Developments
  85. 8.15 Cell Guidance Systems
  86. 8.15.1 Cell Guidance Systems Company Information
  87. 8.15.2 Cell Guidance Systems Business Overview
  88. 8.15.3 Cell Guidance Systems Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cell Guidance Systems Recombinant Human BMP-2 Product Portfolio
  90. 8.15.5 Cell Guidance Systems Recent Developments
  91. 8.16 Biomol GmbH
  92. 8.16.1 Biomol GmbH Company Information
  93. 8.16.2 Biomol GmbH Business Overview
  94. 8.16.3 Biomol GmbH Recombinant Human BMP-2 Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Biomol GmbH Recombinant Human BMP-2 Product Portfolio
  96. 8.16.5 Biomol GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Recombinant Human BMP-2 Value Chain Analysis
  2. 9.1.1 Recombinant Human BMP-2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Recombinant Human BMP-2 Production Mode & Process
  6. 9.2 Recombinant Human BMP-2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Recombinant Human BMP-2 Distributors
  9. 9.2.3 Recombinant Human BMP-2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst